Loading…
for educational and safety purposes
25I-NBOMe and 25I-NBOH both come up in the same conversations; they overlap on Serotonin. 25I-NBOMe: 25I-NBOMe is the N-(2-methoxybenzyl) derivative of 2C-I and the best-known member of the NBOMe family, sometimes sold on blotter paper as "N-bomb." The 2-methoxybenzyl substitution raises 5-HT2A receptor affinity into the sub-nanomolar range and yields a highly potent full agonist, a property exploited in neuroscience through its radiolabeled analogue 11C-CIMBI-5, used as a 5-HT2A agonist radioligand for positron-emission-tomography imaging of the receptor's active state. 25I-NBOH: 25I-NBOH is the N-(2-hydroxybenzyl) derivative of 2C-I and one of the most studied members of the NBOH family.
25I-NBOMe is the N-(2-methoxybenzyl) derivative of 2C-I and the best-known member of the NBOMe family, sometimes sold on blotter paper as "N-bomb." The 2-methoxybenzyl substitution raises 5-HT2A receptor affinity into the sub-nanomolar range and yields a highly potent full agonist, a property exploited in neuroscience through its radiolabeled analogue 11C-CIMBI-5, used as a 5-HT2A agonist radioligand for positron-emission-tomography imaging of the receptor's active state. Pharmacological studies attribute its hallucinogenic activity and its effects on cortical dopamine, serotonin, and glutamate release chiefly to 5-HT2A with a contribution from 5-HT2C, and it is metabolized largely by CYP3A4. The compound is essentially inactive orally and is taken sublingually; a large clinical and forensic literature documents numerous poisonings and deaths, frequently after it was mis-sold as LSD, as well as persistent sequelae such as hallucinogen-persisting perception disorder.
25I-NBOH is the N-(2-hydroxybenzyl) derivative of 2C-I and one of the most studied members of the NBOH family. Its high potency combined with comparatively strong 5-HT2A selectivity has made it a useful pharmacological tool: in mice, selective 5-HT2A activation by 25I-NBOH produces episodes of behavioral arrest and a characteristic slow electroencephalographic waveform that reliably precede the head-twitch response, offering a window onto the neural signature of hallucinogen action. Metabolism proceeds mainly through CYP2D6 alongside direct glucuronidation, and the molecule is thermolabile, degrading to 2C-I under gas chromatography, which has driven the development of dedicated electroanalytical and chromatographic detection methods. It is active at low doses, is used sublingually, is frequently mis-sold as LSD, and has been shown to exert direct adverse cardiovascular effects.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
agonist
agonist
agonist
agonist
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.